应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
GRFS 基立福
耶稣受难日休市 03-28 16:00:00 EDT
6.68
+0.03
+0.45%
盘后
6.60
-0.08
-1.20%
17:46 EDT
最高
6.70
最低
6.50
成交量
102.60万
今开
6.58
昨收
6.65
日振幅
3.01%
总市值
45.36亿
流通市值
36.50亿
总股本
6.79亿
成交额
676.40万
换手率
0.19%
流通股本
5.46亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
基立福盘中异动 早盘大幅下跌10.05%报6.10美元
自选股智能写手 · 03-22
基立福盘中异动 早盘大幅下跌10.05%报6.10美元
基立福盘中异动 股价大涨5.25%
自选股智能写手 · 03-22
基立福盘中异动 股价大涨5.25%
上海莱士(002252.SZ):已与基立福之间就质量管理、代理相关人血白蛋白产品和GDS检测设备及试剂等展开合作
格隆汇资讯 · 03-13
上海莱士(002252.SZ):已与基立福之间就质量管理、代理相关人血白蛋白产品和GDS检测设备及试剂等展开合作
基立福盘中异动 早盘快速跳水5.02%
自选股智能写手 · 03-12
基立福盘中异动 早盘快速跳水5.02%
基立福盘中异动 股价大跌5.00%报6.65美元
自选股智能写手 · 03-11
基立福盘中异动 股价大跌5.00%报6.65美元
基立福2023财年实现净利润64.13百万美元,同比减少70.72%
自选股智能写手 · 03-09
基立福2023财年实现净利润64.13百万美元,同比减少70.72%
基立福盘中异动 早盘急速跳水12.48%
自选股智能写手 · 03-06
基立福盘中异动 早盘急速跳水12.48%
基立福盘中异动 股价大跌5.13%
自选股智能写手 · 03-06
基立福盘中异动 股价大跌5.13%
基立福盘中异动 大幅下挫6.37%报6.61美元
自选股智能写手 · 03-04
基立福盘中异动 大幅下挫6.37%报6.61美元
基立福盘中异动 股价大跌8.25%报6.89美元
自选股智能写手 · 03-01
基立福盘中异动 股价大跌8.25%报6.89美元
基立福宣布完成对上海莱士的尽职调查,今年EBITDA和自由现金流指引欠佳,股价盘中跌超20%
华尔街见闻 · 03-01
基立福宣布完成对上海莱士的尽职调查,今年EBITDA和自由现金流指引欠佳,股价盘中跌超20%
基立福盘中异动 早盘大幅下挫6.32%报8.75美元
自选股智能写手 · 02-29
基立福盘中异动 早盘大幅下挫6.32%报8.75美元
基立福盘中异动 急速上涨5.06%
自选股智能写手 · 02-24
基立福盘中异动 急速上涨5.06%
基立福盘中异动 大幅跳水5.01%报7.97美元
自选股智能写手 · 02-08
基立福盘中异动 大幅跳水5.01%报7.97美元
基立福盘中异动 急速拉升5.11%
自选股智能写手 · 01-27
基立福盘中异动 急速拉升5.11%
基立福盘中异动 股价大涨5.03%报7.72美元
自选股智能写手 · 01-25
基立福盘中异动 股价大涨5.03%报7.72美元
基立福盘中异动 下午盘股价大涨5.25%报7.12美元
自选股智能写手 · 01-23
基立福盘中异动 下午盘股价大涨5.25%报7.12美元
基立福盘中异动 股价大跌5.16%报6.43美元
自选股智能写手 · 01-19
基立福盘中异动 股价大跌5.16%报6.43美元
基立福盘中异动 大幅下挫5.05%报6.96美元
自选股智能写手 · 01-17
基立福盘中异动 大幅下挫5.05%报6.96美元
加载更多
公司概况
公司名称:
基立福
所属市场:
NASDAQ
上市日期:
--
主营业务:
GRIFOLS, S.A.由Jose Antonio Grifols i Roig先生于1940年在西班牙巴塞罗那创建成立,公司是全球主要生物制药企业。公司业务涉及血浆系列产品的研发,生产和大范围销售。Grifols股份有限公司的商业活动包括原材料分类、生产各类型血浆提取产品以及将最终产出售并配送给保健品提供商。
发行价格:
--
{"stockData":{"symbol":"GRFS","market":"US","secType":"STK","nameCN":"基立福","latestPrice":6.68,"timestamp":1711656000000,"preClose":6.65,"halted":0,"volume":1025952,"hourTrading":{"tag":"盘后","latestPrice":6.6,"preClose":6.68,"latestTime":"17:46 EDT","volume":1634,"amount":10898.14,"timestamp":1711662387354},"delay":0,"floatShares":546364643,"shares":679092279,"eps":0.096451,"marketStatus":"耶稣受难日休市","marketStatusCode":7,"change":0.03,"latestTime":"03-28 16:00:00 EDT","open":6.58,"high":6.7,"low":6.5,"amount":6763993.400659,"amplitude":0.030075,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.096451,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1711958400000},"adr":1,"listingDate":1320120000000,"adjPreClose":6.65,"adrRate":1,"dividendRate":0.059745,"preHourTrading":{"tag":"盘前","latestPrice":6.56,"preClose":6.65,"latestTime":"09:27 EDT","volume":3255,"amount":21326.0058165,"timestamp":1711632460047},"postHourTrading":{"tag":"盘后","latestPrice":6.6,"preClose":6.68,"latestTime":"17:46 EDT","volume":1634,"amount":10898.14,"timestamp":1711662387354},"volumeRatio":0.400579},"requestUrl":"/m/hq/s/GRFS","defaultTab":"news","newsList":[{"id":"2421811692","title":"基立福盘中异动 早盘大幅下跌10.05%报6.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421811692","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421811692?lang=zh_cn&edition=full","pubTime":"2024-03-22 21:32","pubTimestamp":1711114330,"startTime":"0","endTime":"0","summary":"北京时间2024年03月22日21时32分,基立福股票出现异动,股价快速跳水10.05%。截至发稿,该股报6.10美元/股,成交量33.667万股,换手率0.05%,振幅0.88%。基立福股票所在的制药行业中,整体涨幅为0.02%。通过在 2011 年收购 Talecris,基立福极大地扩展了其血浆衍生产品组合,且该公司的生物制药业务在 2022 年贡献了 83% 的销售额。基立福还拥有较小的细分市场,包括诊断和生物供应。在收购 Biotest 之后,诊断大约占收入的 10%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032221321087a7b05d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032221321087a7b05d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421207324","title":"基立福盘中异动 股价大涨5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421207324","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421207324?lang=zh_cn&edition=full","pubTime":"2024-03-22 02:44","pubTimestamp":1711046658,"startTime":"0","endTime":"0","summary":"北京时间2024年03月22日02时44分,基立福股票出现波动,股价大幅上涨5.25%。截至发稿,该股报6.62美元/股,成交量131.518万股,换手率0.19%,振幅3.97%。基立福股票所在的制药行业中,整体涨幅为0.32%。通过在 2011 年收购 Talecris,基立福极大地扩展了其血浆衍生产品组合,且该公司的生物制药业务在 2022 年贡献了 83% 的销售额。基立福还拥有较小的细分市场,包括诊断和生物供应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240322024418861e02c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240322024418861e02c6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419957393","title":"上海莱士(002252.SZ):已与基立福之间就质量管理、代理相关人血白蛋白产品和GDS检测设备及试剂等展开合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2419957393","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2419957393?lang=zh_cn&edition=full","pubTime":"2024-03-13 15:22","pubTimestamp":1710314527,"startTime":"0","endTime":"0","summary":"格隆汇3月13日丨上海莱士(002252.SZ)于2024年3月12日接受特定对象调研,就“公司与基立福的合作情况?”,公司回复称,公司已与基立福之间就质量管理、代理相关人血白蛋白产品和GDS检测设备及试剂等展开合作。2024年度,公司预计将与基立福下属公司基立福全球就代理人血白蛋白产品发生的日常关联交易金额约5.62亿美元;与基立福下属公司GDS就代理检测设备及试剂等发生的日常关联交易金额约为0.2亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403131524028b2cbf7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403131524028b2cbf7d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418302755","title":"基立福盘中异动 早盘快速跳水5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2418302755","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418302755?lang=zh_cn&edition=full","pubTime":"2024-03-12 22:04","pubTimestamp":1710252249,"startTime":"0","endTime":"0","summary":"北京时间2024年03月12日22时04分,基立福股票出现异动,股价大幅下跌5.02%。基立福股票所在的制药行业中,整体涨幅为0.79%。同时,基立福将其持有的剩余公司437,069,656股股份对应的表决权委托予海尔集团或其指定关联方行使,占公司总股本的6.58%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031222041087e78350&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031222041087e78350&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418368922","title":"基立福盘中异动 股价大跌5.00%报6.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2418368922","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418368922?lang=zh_cn&edition=full","pubTime":"2024-03-11 21:30","pubTimestamp":1710163826,"startTime":"0","endTime":"0","summary":"北京时间2024年03月11日21时30分,基立福股票出现波动,股价大幅下跌5.00%。截至发稿,该股报6.65美元/股,成交量13.3976万股,换手率0.02%,振幅0.00%。基立福股票所在的制药行业中,整体涨幅为0.00%。通过在 2011 年收购 Talecris,基立福极大地扩展了其血浆衍生产品组合,且该公司的生物制药业务在 2022 年贡献了 83% 的销售额。基立福还拥有较小的细分市场,包括诊断和生物供应。在收购 Biotest 之后,诊断大约占收入的 10%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403112130267a4b92fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403112130267a4b92fa&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418616910","title":"基立福2023财年实现净利润64.13百万美元,同比减少70.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2418616910","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418616910?lang=zh_cn&edition=full","pubTime":"2024-03-09 00:18","pubTimestamp":1709914691,"startTime":"0","endTime":"0","summary":"12月31日,基立福公布财报,公告显示公司2023财年净利润为64.13百万美元,同比减少70.72%;其中营业收入为71.27亿美元,同比增加11.83%,每股基本收益为--。机构评级:截至2023年12月31日,当前有2家机构对基立福目标价做出预测,其中目标均价为15.20美元,其中最低目标价为11.20美元,最高目标价为19.20美元。基立福还拥有较小的细分市场,包括诊断和生物供应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403090018168b18f2a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403090018168b18f2a7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417866297","title":"基立福盘中异动 早盘急速跳水12.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417866297","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417866297?lang=zh_cn&edition=full","pubTime":"2024-03-06 22:32","pubTimestamp":1709735536,"startTime":"0","endTime":"0","summary":"北京时间2024年03月06日22时32分,基立福股票出现异动,股价快速下跌12.48%。截至发稿,该股报5.40美元/股,成交量46.5742万股,换手率0.07%,振幅0.57%。基立福股票所在的制药行业中,整体涨幅为0.42%。通过在 2011 年收购 Talecris,基立福极大地扩展了其血浆衍生产品组合,且该公司的生物制药业务在 2022 年贡献了 83% 的销售额。基立福还拥有较小的细分市场,包括诊断和生物供应。在收购 Biotest 之后,诊断大约占收入的 10%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240306223216875a860d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240306223216875a860d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417459144","title":"基立福盘中异动 股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417459144","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417459144?lang=zh_cn&edition=full","pubTime":"2024-03-06 00:05","pubTimestamp":1709654738,"startTime":"0","endTime":"0","summary":"北京时间2024年03月06日00时05分,基立福股票出现异动,股价急速下跌5.13%。截至发稿,该股报6.29美元/股,成交量69.6494万股,换手率0.10%,振幅3.17%。基立福股票所在的制药行业中,整体跌幅为1.31%。通过在 2011 年收购 Talecris,基立福极大地扩展了其血浆衍生产品组合,且该公司的生物制药业务在 2022 年贡献了 83% 的销售额。基立福还拥有较小的细分市场,包括诊断和生物供应。在收购 Biotest 之后,诊断大约占收入的 10%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030600053887e7621b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030600053887e7621b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416847144","title":"基立福盘中异动 大幅下挫6.37%报6.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2416847144","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416847144?lang=zh_cn&edition=full","pubTime":"2024-03-04 22:31","pubTimestamp":1709562666,"startTime":"0","endTime":"0","summary":"北京时间2024年03月04日22时31分,基立福股票出现波动,股价大幅跳水6.37%。截至发稿,该股报6.61美元/股,成交量20.4666万股,换手率0.03%,振幅0.42%。基立福股票所在的制药行业中,整体涨幅为1.24%。通过在 2011 年收购 Talecris,基立福极大地扩展了其血浆衍生产品组合,且该公司的生物制药业务在 2022 年贡献了 83% 的销售额。基立福还拥有较小的细分市场,包括诊断和生物供应。在收购 Biotest 之后,诊断大约占收入的 10%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403042231068b026257&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403042231068b026257&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416646027","title":"基立福盘中异动 股价大跌8.25%报6.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2416646027","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416646027?lang=zh_cn&edition=full","pubTime":"2024-03-01 22:32","pubTimestamp":1709303524,"startTime":"0","endTime":"0","summary":"北京时间2024年03月01日22时32分,基立福股票出现波动,股价急速下挫8.25%。截至发稿,该股报6.89美元/股,成交量83.3288万股,换手率0.12%,振幅1.20%。基立福股票所在的制药行业中,整体涨幅为1.13%。基立福还拥有较小的细分市场,包括诊断和生物供应。消息层面,截至22时32分,《基立福称出售上海莱士股份的尽职调查已于周四结束》资讯为影响基立福的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030122320487d7ece4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030122320487d7ece4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416068641","title":"基立福宣布完成对上海莱士的尽职调查,今年EBITDA和自由现金流指引欠佳,股价盘中跌超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416068641","media":"华尔街见闻","top":-1,"share":"https://www.laohu8.com/m/news/2416068641?lang=zh_cn&edition=full","pubTime":"2024-03-01 06:59","pubTimestamp":1709247555,"startTime":"0","endTime":"0","summary":"基立福西班牙股价跌幅在尾盘扩大至超过21%,创1月9日卖空者发布报告以来最大盘中跌幅,报9.31欧元。欧市盘中,该公司宣布今日完成对 上海莱士 的尽职调查,基立福公司行政问题造成业绩审计被延后,管理层预计新增自由现金流将放缓——这将逊色于市场预期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030107080987d44313&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030107080987d44313&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2415547711","title":"基立福盘中异动 早盘大幅下挫6.32%报8.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2415547711","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2415547711?lang=zh_cn&edition=full","pubTime":"2024-02-29 22:32","pubTimestamp":1709217148,"startTime":"0","endTime":"0","summary":"北京时间2024年02月29日22时32分,基立福股票出现异动,股价快速下挫6.32%。截至发稿,该股报8.75美元/股,成交量18.8707万股,换手率0.03%,振幅0.54%。基立福股票所在的制药行业中,整体跌幅为0.62%。通过在 2011 年收购 Talecris,基立福极大地扩展了其血浆衍生产品组合,且该公司的生物制药业务在 2022 年贡献了 83% 的销售额。基立福还拥有较小的细分市场,包括诊断和生物供应。在收购 Biotest 之后,诊断大约占收入的 10%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022922322887d23f40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022922322887d23f40&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413910917","title":"基立福盘中异动 急速上涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2413910917","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413910917?lang=zh_cn&edition=full","pubTime":"2024-02-24 01:12","pubTimestamp":1708708322,"startTime":"0","endTime":"0","summary":"北京时间2024年02月24日01时12分,基立福股票出现异动,股价大幅上涨5.06%。截至发稿,该股报9.14美元/股,成交量77.1534万股,换手率0.11%,振幅2.82%。基立福股票所在的制药行业中,整体涨幅为0.11%。通过在 2011 年收购 Talecris,基立福极大地扩展了其血浆衍生产品组合,且该公司的生物制药业务在 2022 年贡献了 83% 的销售额。基立福还拥有较小的细分市场,包括诊断和生物供应。在收购 Biotest 之后,诊断大约占收入的 10%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402240112027913f25e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402240112027913f25e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2409725392","title":"基立福盘中异动 大幅跳水5.01%报7.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2409725392","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2409725392?lang=zh_cn&edition=full","pubTime":"2024-02-08 01:04","pubTimestamp":1707325491,"startTime":"0","endTime":"0","summary":"北京时间2024年02月08日01时04分,基立福股票出现异动,股价大幅下挫5.01%。截至发稿,该股报7.97美元/股,成交量64.9203万股,换手率0.10%,振幅5.30%。基立福股票所在的制药行业中,整体涨幅为1.79%。通过在 2011 年收购 Talecris,基立福极大地扩展了其血浆衍生产品组合,且该公司的生物制药业务在 2022 年贡献了 83% 的销售额。基立福还拥有较小的细分市场,包括诊断和生物供应。在收购 Biotest 之后,诊断大约占收入的 10%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402080104527a425408&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402080104527a425408&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2406714338","title":"基立福盘中异动 急速拉升5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2406714338","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2406714338?lang=zh_cn&edition=full","pubTime":"2024-01-27 02:08","pubTimestamp":1706292482,"startTime":"0","endTime":"0","summary":"北京时间2024年01月27日02时08分,基立福股票出现异动,股价急速上涨5.11%。截至发稿,该股报8.02美元/股,成交量69.2106万股,换手率0.10%,振幅3.92%。基立福股票所在的制药行业中,整体涨幅为0.81%。通过在 2011 年收购 Talecris,基立福极大地扩展了其血浆衍生产品组合,且该公司的生物制药业务在 2022 年贡献了 83% 的销售额。基立福还拥有较小的细分市场,包括诊断和生物供应。在收购 Biotest 之后,诊断大约占收入的 10%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401270208037a3ec172&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401270208037a3ec172&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2406476326","title":"基立福盘中异动 股价大涨5.03%报7.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2406476326","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2406476326?lang=zh_cn&edition=full","pubTime":"2024-01-25 04:09","pubTimestamp":1706126972,"startTime":"0","endTime":"0","summary":"北京时间2024年01月25日04时09分,基立福股票出现异动,股价快速拉升5.03%。截至发稿,该股报7.72美元/股,成交量131.585万股,换手率0.19%,振幅3.33%。基立福股票所在的制药行业中,整体涨幅为0.31%。通过在 2011 年收购 Talecris,基立福极大地扩展了其血浆衍生产品组合,且该公司的生物制药业务在 2022 年贡献了 83% 的销售额。基立福还拥有较小的细分市场,包括诊断和生物供应。在收购 Biotest 之后,诊断大约占收入的 10%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240125040932790bd4f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240125040932790bd4f9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2405181629","title":"基立福盘中异动 下午盘股价大涨5.25%报7.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2405181629","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2405181629?lang=zh_cn&edition=full","pubTime":"2024-01-23 02:35","pubTimestamp":1705948530,"startTime":"0","endTime":"0","summary":"北京时间2024年01月23日02时35分,基立福股票出现波动,股价大幅拉升5.25%。截至发稿,该股报7.12美元/股,成交量71.2143万股,换手率0.10%,振幅2.81%。基立福股票所在的制药行业中,整体跌幅为0.01%。通过在 2011 年收购 Talecris,基立福极大地扩展了其血浆衍生产品组合,且该公司的生物制药业务在 2022 年贡献了 83% 的销售额。基立福还拥有较小的细分市场,包括诊断和生物供应。在收购 Biotest 之后,诊断大约占收入的 10%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240123023530861cc793&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240123023530861cc793&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2404755521","title":"基立福盘中异动 股价大跌5.16%报6.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2404755521","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2404755521?lang=zh_cn&edition=full","pubTime":"2024-01-19 01:54","pubTimestamp":1705600443,"startTime":"0","endTime":"0","summary":"北京时间2024年01月19日01时54分,基立福股票出现波动,股价急速跳水5.16%。截至发稿,该股报6.43美元/股,成交量155.522万股,换手率0.23%,振幅4.12%。基立福股票所在的制药行业中,整体跌幅为1.09%。通过在 2011 年收购 Talecris,基立福极大地扩展了其血浆衍生产品组合,且该公司的生物制药业务在 2022 年贡献了 83% 的销售额。基立福还拥有较小的细分市场,包括诊断和生物供应。在收购 Biotest 之后,诊断大约占收入的 10%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240119015403790a1a2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240119015403790a1a2c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2404517423","title":"基立福盘中异动 大幅下挫5.05%报6.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2404517423","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2404517423?lang=zh_cn&edition=full","pubTime":"2024-01-17 22:31","pubTimestamp":1705501866,"startTime":"0","endTime":"0","summary":"北京时间2024年01月17日22时31分,基立福股票出现波动,股价急速下挫5.05%。截至发稿,该股报6.96美元/股,成交量27.2827万股,换手率0.04%,振幅0.93%。基立福股票所在的制药行业中,整体涨幅为0.17%。通过在 2011 年收购 Talecris,基立福极大地扩展了其血浆衍生产品组合,该公司的生物制药业务在 2022 年贡献了 83% 的销售额。基立福还拥有较小的细分市场,包括诊断和生物供应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024011722310687c514da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024011722310687c514da&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.grifols.com","stockEarnings":[{"period":"1week","weight":-0.0147},{"period":"1month","weight":-0.2817},{"period":"3month","weight":-0.4221},{"period":"6month","weight":-0.2691},{"period":"1year","weight":-0.0709},{"period":"ytd","weight":-0.4221}],"compareEarnings":[{"period":"1week","weight":0.0017},{"period":"1month","weight":0.0318},{"period":"3month","weight":0.1005},{"period":"6month","weight":0.2236},{"period":"1year","weight":0.3033},{"period":"ytd","weight":0.1005}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"GRIFOLS, S.A.由Jose Antonio Grifols i Roig先生于1940年在西班牙巴塞罗那创建成立,公司是全球主要生物制药企业。公司业务涉及血浆系列产品的研发,生产和大范围销售。Grifols股份有限公司的商业活动包括原材料分类、生产各类型血浆提取产品以及将最终产出售并配送给保健品提供商。","yearOnYearQuotes":[{"month":1,"riseRate":0.692308,"avgChangeRate":0.006684},{"month":2,"riseRate":0.538462,"avgChangeRate":0.001444},{"month":3,"riseRate":0.461538,"avgChangeRate":-0.010634},{"month":4,"riseRate":0.583333,"avgChangeRate":0.024919},{"month":5,"riseRate":0.416667,"avgChangeRate":0.0039},{"month":6,"riseRate":0.5,"avgChangeRate":0.031344},{"month":7,"riseRate":0.615385,"avgChangeRate":0.008869},{"month":8,"riseRate":0.153846,"avgChangeRate":-0.0601},{"month":9,"riseRate":0.461538,"avgChangeRate":-0.018909},{"month":10,"riseRate":0.538462,"avgChangeRate":0.004817},{"month":11,"riseRate":0.538462,"avgChangeRate":0.037397},{"month":12,"riseRate":0.692308,"avgChangeRate":0.028882}],"exchange":"NASDAQ","name":"基立福","nameEN":"Grifols SA"},"APP":{"userAgent":"claudebot","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.3","shortVersion":"4.22.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"基立福(GRFS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供基立福(GRFS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"基立福,GRFS,基立福股票,基立福股票老虎,基立福股票老虎国际,基立福行情,基立福股票行情,基立福股价,基立福股市,基立福股票价格,基立福股票交易,基立福股票购买,基立福股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"基立福(GRFS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供基立福(GRFS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}